Talphera (TLPH) EBT Margin Growth (1y) (2012 - 2023)
Talphera (TLPH) EBT Margin Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,258.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 132.00 |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 205,130.00 |
| Mar 31, 2022 | -21,129.00 |
| Dec 31, 2021 | -39.46 Mn |
| Sep 30, 2021 | 16,013.00 |
| Jun 30, 2021 | -199,679.00 |
| Mar 31, 2021 | 243,837.00 |
| Dec 31, 2020 | 182,802.00 |
| Sep 30, 2020 | 144,114.00 |
| Jun 30, 2020 | 109,292.00 |
| Mar 31, 2020 | 263,294.00 |
| Dec 31, 2019 | -98,781.00 |
| Sep 30, 2019 | 121,059.00 |
| Jun 30, 2019 | -3,032.00 |
| Mar 31, 2019 | -441,838.00 |
| Dec 31, 2018 | -61,780.00 |
| Sep 30, 2018 | -242,939.00 |
| Jun 30, 2018 | -79,734.00 |
| Mar 31, 2018 | -205,841.00 |
| Dec 31, 2017 | -128,035.00 |
| Sep 30, 2017 | -53,531.00 |